Vanessa M. Noriega

Icahn School of Medicine at Mount Sinai

Papers

1

Total Citations

27

H-Index

1

About

Vanessa M. Noriega is a leading virologist whose research focuses on the mechanisms of human cytomegalovirus (CMV) entry and the development of novel antiviral strategies. Her most impactful work centers on identifying broadly neutralizing epitopes within the CMV envelope, particularly the essential glycoprotein complex gH/gL/gO (gH-trimer), which is required for infection across all cell types. In her landmark 2016 study, Noriega performed a functional screen for anti-CMV biologics, pinpointing a conserved epitope that elicits potent, broad neutralization—a discovery with direct implications for vaccine design and immunotherapeutic development. This work, which has garnered 27 citations, represents a critical step toward understanding how to block CMV’s wide tropism and life-long persistence. Noriega’s contributions have advanced the field’s knowledge of viral entry pathways and provided a blueprint for targeting essential envelope proteins. Her research continues to shape the fight against CMV, a major cause of disease in immunocompromised patients and newborns, making her a key figure in modern virology.

Research Focus

Key Achievements

1
H-Index
1
Papers
27
Total Citations
27
Avg Citations/Paper
🏆 Most Cited Paper
Functional screening for anti-CMV biologics identifies a broadly neutralizing epitope of an essential envelope protein
27 citations · 2016
📈 Most Prolific Year: 2016 (1 Papers)
🤝 Key Collaborators: 7
🏛 Institutions: Icahn School of Medicine at Mount Sinai

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago